“Recombinant Nanobiotechnology for Swallowable Insulin: Innovations in Noninvasive Diabetes Therapy: Recombinant Oral Insulin Nanobiotechnology”, Ricos Biol., vol. 3, no. 11, pp. 15–19, Nov. 2025, doi: 10.33687/ricosbiol.03.011.90.